R Büttner1, N Friedrichs2. 1. Institut für Pathologie, Medizinische Fakultät und Uniklinik Köln, Universität Köln, Kerpener Str. 62, 50937, Köln, Deutschland. 2. Institut für Pathologie, Medizinische Fakultät und Uniklinik Köln, Universität Köln, Kerpener Str. 62, 50937, Köln, Deutschland. nicolaus.friedrichs@uk-koeln.de.
Abstract
BACKGROUND: Hereditary nonpolyposis colorectal cancer (Lynch/HNPCC syndrome) is based on a germline mutation inducing increased occurrence of colorectal cancer and extracolonic carcinomas in young age. The German HNPCC consortium aims to increase awareness for detection of hereditary colon cancer among patients and physicians. OBJECTIVES: Reliable detection of HNPCC patients is based on a thorough documentation of patients' medical history and on further diagnostics delivered by human genetics and surgical pathology. This manuscript presents a standardized diagnostic concept. METHODS: Relevant literature is reviewed and discussed and diagnostic parameters are outlined. In addition, operating figures of the German HNPCC consortium are presented. RESULTS: The German HNPCC consortium is based on an efficient cooperation between clinical physicians, human geneticists, and surgical pathologists. After a funding period from the Deutsche Krebshilfe, HNPCC diagnostics and preventive medical examinations were transferred into standard care in Germany. In total, 5770 families (8873 patients) were included in HNPCC diagnostics. To date, in 1296 families, mutations of the MLH1-, MSH2-, MSH6-, PMS2-, or EPCAM-gene have been detected. Furthermore, 612 pathogenic variants and 325 variants of unknown significance were found. CONCLUSIONS: Reliable detection of HNPCC patients is based on a standardized diagnostic concept, which has been established within the German HNPCC consortium.
BACKGROUND:Hereditary nonpolyposis colorectal cancer (Lynch/HNPCC syndrome) is based on a germline mutation inducing increased occurrence of colorectal cancer and extracolonic carcinomas in young age. The German HNPCC consortium aims to increase awareness for detection of hereditary colon cancer among patients and physicians. OBJECTIVES: Reliable detection of HNPCC patients is based on a thorough documentation of patients' medical history and on further diagnostics delivered by human genetics and surgical pathology. This manuscript presents a standardized diagnostic concept. METHODS: Relevant literature is reviewed and discussed and diagnostic parameters are outlined. In addition, operating figures of the German HNPCC consortium are presented. RESULTS: The German HNPCC consortium is based on an efficient cooperation between clinical physicians, human geneticists, and surgical pathologists. After a funding period from the Deutsche Krebshilfe, HNPCC diagnostics and preventive medical examinations were transferred into standard care in Germany. In total, 5770 families (8873 patients) were included in HNPCC diagnostics. To date, in 1296 families, mutations of the MLH1-, MSH2-, MSH6-, PMS2-, or EPCAM-gene have been detected. Furthermore, 612 pathogenic variants and 325 variants of unknown significance were found. CONCLUSIONS: Reliable detection of HNPCC patients is based on a standardized diagnostic concept, which has been established within the German HNPCC consortium.
Authors: Henry T Lynch; Carrie Snyder; Janine M Davies; Stephen Lanspa; Jane Lynch; Zoran Gatalica; Victoria Graeve; Jason Foster Journal: Fam Cancer Date: 2010-12 Impact factor: 2.375
Authors: Kandelaria Rumilla; Karen V Schowalter; Noralane M Lindor; Brittany C Thomas; Kara A Mensink; Steven Gallinger; Spring Holter; Polly A Newcomb; John D Potter; Mark A Jenkins; John L Hopper; Tiffany I Long; Daniel J Weisenberger; Robert W Haile; Graham Casey; Peter W Laird; Loic Le Marchand; Stephen N Thibodeau Journal: J Mol Diagn Date: 2010-12-23 Impact factor: 5.568
Authors: Verena Steinke; Christoph Engel; Reinhard Büttner; Hans Konrad Schackert; Wolff H Schmiegel; Peter Propping Journal: Dtsch Arztebl Int Date: 2013-01-18 Impact factor: 5.594
Authors: Marcus Bettstetter; Stefan Dechant; Petra Ruemmele; Corinna Vogel; Katrin Kurz; Monika Morak; Gisela Keller; Elke Holinski-Feder; Ferdinand Hofstaedter; Wolfgang Dietmaier Journal: Lab Invest Date: 2008-10-20 Impact factor: 5.662
Authors: F S Leach; N C Nicolaides; N Papadopoulos; B Liu; J Jen; R Parsons; P Peltomäki; P Sistonen; L A Aaltonen; M Nyström-Lahti Journal: Cell Date: 1993-12-17 Impact factor: 41.582